Risk of myocarditis and pericarditis after a COVID-19 mRNA v

In a nationwide, self-controlled case series analysis conducted in England, Julia Stowe and colleagues investigate the effect of prior SARS CoV-2 infection on the risk of hospital admission for myocarditis or pericarditis after primary or booster vaccination and after a confirmed SARS-CoV-2 infection.

Related Keywords

United Kingdom , Israel , Wuhan , Hubei , China , Sweden , Israeli , , Health Service Control Of Patient Information , United Kingdom Health Security Agency , National Health Service , United Kingdom Health Security Agency Second , London School Of Hygiene , National Immunisation Management System , Severe Acute Respiratory Syndrome Coronavirus , Secondary Uses Service , Second Generation Surveillance , Creative Commons Attribution License , Health Service , Patient Information , National Institute , Health Research Protection Unit , London School , Tropical Medicine , Grant Reference , Coronavirus Disease , Emergency Care Data Set , Second Generation Surveillance System , Secondary Uses , Care Data Set , Systematized Nomenclature , Clinical Terms , Generation Surveillance System , Booster Doses , Cardiovascular Disease Risk , Myocarditis , Sars Cov 2 , Vaccination And Immunization , Covid 19 , Vaccines , Respiratory Infections ,